Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

23Andme Holding Co. (NQ: ME )

3.230 +0.080 (+2.54%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about 23Andme Holding Co.

< Previous 1 2 3 4 5 6 7 Next >
Struggling Genetic Testing Company 23andMe To Lay Off 40% Of Its Workforce, Discontinues All Therapeutic Programs
23andMe restructures, cutting 40% of its workforce and ending its therapeutic programs to save $35 million annually while exploring strategic alternatives. 
Via Benzinga
Earnings Scheduled For November 12, 2024
Via Benzinga
Earnings Outlook For 23andMe Holding
Via Benzinga
ASML's Latest Chapter in the Semiconductor Story
We've also got a look at genetic testing company 23andMe . 
Via The Motley Fool
Author Alok Sama on OpenAI, Bubbles, and When to Sell
We're talking tech. 
Via The Motley Fool
Legal Battle Brews Over 23andMe's Customer Data Breach Settlement And Arbitration Claimants
Lawyer raises objections to 23andMe's proposed $30 million settlement, arguing it undermines arbitration rights for 5,000 customers following a data breach. The court is set to review the case in late... 
Via Benzinga
Topics Data Breach
Exposures Information Security
Looking Into 23andMe Holding's Recent Short Interest
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Independent Board Members Of Penny Stock 23andMe Resign, Call Out CEO Anne Wojcicki For Not 'Actionable Proposal' Despite Ample Time
23andMe's independent board members resigned after months of waiting for Anne Wojcicki's fully financed proposal to take the company private. 
Via Benzinga
General Mills, Steelcase And 3 Stocks To Watch Heading Into Wednesday
Via Benzinga
Why Affirm Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
ME Stock Earnings: 23andMe Holding Beats EPS, Misses Revenue for Q1 2025
ME stock results show that 23andMe Holding beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2025. 
Via InvestorPlace
ME Stock Alert: CEO Anne Wojcicki Enters $200 Million Buyout Offer for 23andMe
23andMe stock is up on Friday as investors react to an offer from the company's founder to take it private for 40 cents per share for ME. 
Via InvestorPlace
The 3 Best Personalized Nutrition Stocks to Buy Now
Explore personalized nutrition stocks capitalizing on AI, machine learning and genetic profiling to provide targeted dietary solutions. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 High-Dividend Stocks to Buy if You Are Seeking Consistent Payouts
Hercules Capital, Pfizer and Target offer stability, growth potential and reliable dividends in the realm of high-dividend stocks. 
Via InvestorPlace
3 Ultra-High-Yield Dividend Stocks to Buy Hand Over Fist Right This Instant
Business development companies can be a lucrative source of passive income. 
Via The Motley Fool
3 Penny Stocks That Can Deliver Over 5,000% Upside by 2025: June Edition
Don’t miss out on these three penny stocks, which have amazing potential to take off following upcoming business developments this year. 
Via InvestorPlace
Why 23andMe Stock Tumbled 10% on Tuesday
Is altruism a good idea for an unprofitable capitalistic enterprise? 
Via The Motley Fool
ME Stock Earnings: 23andMe Holding Beats EPS, Beats Revenue for Q4 2024
ME stock results show that 23andMe Holding beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
This Technology Company Is Being Acquired at a Shocking 207% Premium -- and These 2 Stocks Could Be Next
Matterport is being acquired by a real estate giant, but it might not be the last ex-SPAC to go this route. 
Via The Motley Fool
Nasdaq Down 0.5%; Lithium Americas Shares Slide
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Crude Oil Edges Lower; Bio-Path Holdings Shares Spike Higher
Via Benzinga
Exposures Fossil Fuels
Once Valued At Billions, 23andMe's CEO Considers Privatization To Secure Company's Future
Anne Wojcicki, CEO of 23andMe mulls taking the genetics company private amid market challenges. With declining revenue and a focus shift to drug development, the move seeks funding for potential... 
Via Benzinga
Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why Is Lithium Americas (LAC) Stock Down 28% Today?
Lithium Americas stock is falling on Thursday after the lithium mining company announced the pricing of a public offering for LAC shares. 
Via InvestorPlace
Walgreens Layoffs 2024: What to Know About the Latest WBA Job Cuts
Walgreens layoffs are in the news Thursday after the pharmacy chain announced plans to cut jobs in Chicago while reducing employees' hours. 
Via InvestorPlace
Topics Workforce
Exposures Layoff
ME Stock Alert: CEO Anne Wojcicki Seeks to Save 23andMe in Take-Private Deal
23andMe stock is rallying on Wednesday after the company's CEO announced plans to take ME shares private in a potential deal. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.